Nkgen Biotech Inc (NKGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,260 | 1,443 | 1,723 | 1,894 | 2,012 |
| TOTAL | $1,798 | $2,104 | $2,535 | $2,847 | $3,120 |
| Non-Current Assets | |||||
| Investments And Advances | 171,825 | 171,700 | 171,656 | 171,636 | 171,615 |
| Other Non-Current Assets | 15 | 0 | 0 | 0 | 0 |
| TOTAL | $171,840 | $171,700 | $171,656 | $171,636 | $171,615 |
| Total Assets | $173,638 | $173,804 | $174,191 | $174,483 | $174,735 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 131 | 78 | 52 | 35 | 17 |
| Accrued Expenses | 2,596 | 2,036 | 1,656 | 630 | 184 |
| TOTAL | $2,857 | $2,193 | $1,893 | $799 | $268 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 172,890 | 174,495 | 177,186 | 177,234 | 163,461 |
| TOTAL | $174,992 | $180,502 | $183,193 | $183,240 | $169,467 |
| Total Liabilities | $177,849 | $182,695 | $185,086 | $184,039 | $169,735 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 21,452 | 21,453 | 21,452 | 21,453 | 21,453 |
| Common Shares | 0 | 0 | 0 | 0 | 1 |
| Retained earnings | -4,211 | -8,892 | -10,895 | -9,556 | -4,346 |
| TOTAL | $-4,211 | $-8,891 | $-10,895 | $-9,556 | $5,000 |
| Total Liabilities And Equity | $173,638 | $173,804 | $174,191 | $174,483 | $174,735 |